PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Novozymes Biopolymer Wins Gold Innovation Award for Novel Hyaluronic Acid HyaCare - Novozymes Biopolymer, part of Novozymes, world leader in bio-innovation, today announced winning the Gold Innovation Award at CPhI worldwide conference in Frankfurt, Germany, for its novel form of hyaluronic acid (HA)
Novozymes Biopolymer Wins Gold Innovation Award for Novel Hyaluronic Acid HyaCare

 

NewswireToday - /newswire/ - Bagsvaerd, Denmark, 2008/12/19 - Novozymes Biopolymer, part of Novozymes, world leader in bio-innovation, today announced winning the Gold Innovation Award at CPhI worldwide conference in Frankfurt, Germany, for its novel form of hyaluronic acid (HA).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Novozymes Biopolymer, part of Novozymes, world leader in bioinnovation, today announced winning the Gold Innovation Award at CPhI worldwide conference in Frankfurt, Germany, for its novel form of hyaluronic acid (HA) HyaCare®. The CPhI Innovation Award is established as the showcase for exceptional work in developing research and technology, setting the standards for the pharmaceutical manufacturing industry. The judging panel took into account a number of factors including effective development of the technology and its key benefits to the pharmaceutical industry.

Traditionally, HA is derived from rooster combs or from strains of pathogenic Streptococcal bacteria, which allows for a high degree of contamination by animal proteins, viruses and end toxins present in the bacterial genome. HyaCare is developed under animal-free conditions with no animal derived ingredients used at any stage of the manufacturing process. Novozymes Biopolymer developed this unique non-pathogenic method for producing HA by fermentation of a novel production strain, Bacillus subtilis. The Bacillus strain is a well-characterised, endotoxin free organism that is generally regarded as safe by the US Food and Drug Administration (FDA).

Animal-free ingredients offer an ethical, safe solution for the production of ingredients that form the basis of biological products. Popularity of these ingredients is increasing as regulatory authorities begin to enforce strict quality measures on products to improve safety, particularly with potential contamination risks from pathogens such as viruses in animal-derived ingredients.

HyaCare is produced using Novozymes Biopolymer patented, advanced and safe fermentation and purification technology which results in a completely pure product. While both rooster comb and Streptococcus derived HAs must be recovered using powerful organic solvents, this product is secreted outside the bacterial cell and can be collected using only water, eliminating the need for organic solvents. HyaCare is used for a wide range of solubility applications in the pharmaceutical sector, including ophthalmology, wound healing and osteoarthritis as well as in cosmetics and anti-wrinkle creams.

“HyaCare is a breakthrough in safety and purity and we are delighted to have won the gold award in recognition of this,” explains Kim Budolph Johansen, Global Business Manager at Novozymes A/S. “HyaCare is the world's first hyaluronic acid that is 100% free of animal-derived raw materials and organic solvent remnants and as such has many advantages over existing methods of manufacture.”

About Novozymes
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow’s industrial biosolutions, improving our customers' business and the use of our planet's resources.

With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever-changing marketplace.

Novozymes’ natural solutions enhance and promote everything from removing trans-fats in food, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature’s potential is evidenced by over 4,500 patents, showing what is possible when nature and technology join forces.

Our 4,500+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow.

Detailed descriptions of the Company and its products and services can be viewed on the Company's website.

Contacts:
Novozymes Biopharma UK Ltd
Sally Kent, Marketing Manager
T: +44 115 9551209
E: syke[.]novozymes.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Novozymes Biopolymer Wins Gold Innovation Award for Novel Hyaluronic Acid HyaCare

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Fiona Robinson 
+44 1477 539539
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)